S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today

Kevin Travers16:12 ET

Assessing AbbVie: Insights From 17 Financial Analysts

Benzinga14:00 ET

8 Health Care Stocks Whale Activity In Today's Session

Benzinga12:35 ET

Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock

Kevin Travers11:06 ET

Resilience Partners With Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD

BusinesswireJan 8 09:00 ET

AbbVie Price Target Cut to $211.00/Share From $215.00 by Truist Securities

Dow JonesJan 8 06:50 ET · Ratings